CureGene Pharmaceutical

Shanghai, China · Founded 2018 · Privately Held (backing)

Developer and provider of drugs designed to treat cardiovascular and cerebrovascular diseases. CureGene Pharmaceutical is based in Shanghai, China and was founded in 2018. It has raised $27.8 million.

Last price · $/share
—
Implied valuation
—
Total raised
$27.8M
Last round
—

Who backs CureGene Pharmaceutical?

14 investors
InvestorType
Yonghua CapitalOther
Guangdong Technology Financial GroupOther
Tailong VCOther
Infinity GroupPE / buyout
Hankang CapitalVenture capital
Qingdao Conson Financial HoldingsOther
Nanometer VentureOther
Yongjin GroupOther
Aeonmed—
Ausun Pharma—
+ 4 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

CureGene Pharmaceutical investors

14 investors are on record for CureGene Pharmaceutical, including Yonghua Capital, Guangdong Technology Financial Group, Tailong VC and Infinity Group.

Free account
More of CureGene Pharmaceutical with a free account
  • ·The complete investor list: 14 names
  • ·Watch CureGene Pharmaceutical: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 14 firms already write checks for companies like CureGene Pharmaceutical. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View